When Competing Trials Start Eating Your Enrollment
Not every enrollment slowdown is a site problem. Sometimes it's a portfolio problem. Here's how to tell the difference and what to do about it.
Newsletter
Enrollment Slipped Last Week. You'll Find Out Next Month
Your local call center knows exactly how every agent performed today. Your clinical trial sites? They're still filling out spreadsheets.
Why a Tenured Stanford Professor Walked Away to Build What Academia Couldn't
"The last paragraph in a paper is often what you really want to be doing,"
Two Decades, Two ALS Programs, One Key Insight
In 1996, a young psychiatrist named Joseph Palumbo joined Cephalon to work on myotrophin, a promising ALS candidate. It didn't succeed. What he learned shaped the first ALS approval in over 20 years.
Your Best Sites Have Already Solved Your Patient Recruitment Problem
How "positive deviance" can help you find what's working and scale it
Power's 2025 Recap: What 10x Enrollment Growth Taught Us
The operational insights behind our biggest year in patient recruitment
Science Saved It, Execution Proved It: Schizophrenia's First New Mechanism in 70 Years
How a time-constrained 6-month proof-of-concept study and disciplined trial methodology transformed a shelved compound into a $14 billion breakthrough